Document is current
Any future updates will be listed below
-
Authors
Wang, Xiangyu
Zhang, Shuzhen
Chua, Eng Guan
He, Yongsheng
Li, Xiaofeng
Liu, Aijun
Chen, Haiting
Wise, Michael J.
Marshall, Barry J.
Sun, Dayong
Li, Xuehong
Tay, Chin Yen https://orcid.org/0000-0001-9705-4010
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2000041570 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
A re-testing range is recommended for 13C- and 14C-urea breath tests for Helicobacter pylori infection in China
https://doi.org/10.1186/s13099-021-00435-3
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81902022)
Sanming Project of Medicine in Shenzhen (SZSM201510050)
- License Information
-
More Information
Article History
Received: 22 March 2021
Accepted: 7 June 2021
First Online: 12 June 2021
Declarations
:
: This study was approved by the research ethics committee of Shenzhen Kuichong People’s Hospital (Reference no. 201609) and registered at (Reference no. ChiCTR2000041570). Informed consents were obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.
